Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL.
Saved in:
| Title: | Pretreatment SUV |
|---|---|
| Authors: | Strati, Paolo1 (AUTHOR), Ahmed, Mohamed Amin1 (AUTHOR), Nastoupil, Loretta J.1 (AUTHOR), Feng, Lei2 (AUTHOR), Hagemeister, Fredrick B.1 (AUTHOR), Fayad, Luis E.1 (AUTHOR), Rodriguez, Maria A.1 (AUTHOR), Samaniego, Felipe1 (AUTHOR), Wang, Michael1 (AUTHOR), Westin, Jason R.1 (AUTHOR), Lee, Hun J.1 (AUTHOR), Iyer, Swaminathan P.1 (AUTHOR), Parmar, Simrit1 (AUTHOR), Ahmed, Sairah1 (AUTHOR), Nair, Ranjit1 (AUTHOR), Steiner, Raphael E.1 (AUTHOR), Noorani, Mansoor1 (AUTHOR), Flowers, Christopher R.1 (AUTHOR), Davis, R. Eric1 (AUTHOR), Fowler, Nathan H.1 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Jun2020, Vol. 61 Issue 6, p1380-1387. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
